Abstract
IntroductionPlatelet dysfunction (thrombocytopathy) is a major problem in the bleeding patient and increases morbidity and healthcare costs. The thrombocytopathy resulting from cardiopulmonary bypass (CPB) can be used to study therapies...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have